Author:
Mimura Hidefumi,Akita Sadanori,Fujino Akihiro,Jinnin Masatoshi,Ozaki Mine,Osuga Keigo,Nakaoka Hiroki,Morii Eiichi,Kuramochi Akira,Aoki Yoko,Arai Yasunori,Aramaki Noriko,Inoue Masanori,Iwashina Yuki,Iwanaka Tadashi,Ueno Shigeru,Umezawa Akihiro,Ozeki Michio,Ochi Junko,Kinoshita Yoshiaki,Kurita Masakazu,Seike Shien,Takakura Nobuyuki,Takahashi Masataka,Tachibana Takao,Chuman Kumiko,Nagata Shuji,Narushima Mitsunaga,Niimi Yasunari,Nosaka Shunsuke,Nozaki Taiki,Hashimoto Kazuki,Hayashi Ayato,Hirakawa Satoshi,Fujikawa Atsuko,Hori Yumiko,Matsuoka Kentaro,Mori Hideki,Yamamoto Yuki,Yuzuriha Shunsuke,Rikihisa Naoaki,Watanabe Shoji,Watanabe Shinichi,Kuroda Tatsuo,Sugawara Shunsuke,Ishikawa Kosuke,Sasaki Satoru
Abstract
AbstractThe objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging
Reference421 articles.
1. ISSVA Classification of Vascular Anomalies© 2014 International Society for the Study of Vascular Anomalies. http://www.issva.org/classification. Accessed Apr 2014.
2. Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics. 2015;136:e203–14.
3. Clinical practice guidelines for vascular anomalies. The Research Committee of Intractable Vascular Anomalies, Research on Measures for Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan. 2013. http://www.marianna-u.ac.jp/va/files/vascular%20anomalies%20practice%20guideline%202013.pdf. Accessed 29 Mar 2013 (Japanese).
4. Fukui T, Yamaguchi N, Morizane T, Yoshida M, Kojimahara N (eds). Minds handbook for clinical practice guideline development 2014. Ver 1.0, Tokyo: Minds Guideline Center, Japan Council for Quality Health Care. 2014. http://minds4.jcqhc.or.jp/minds/guideline/pdf/MindsHB2014.pdf. Accessed 1 Feb 2015.
5. Morizane T, Yoshida M (eds). Minds manual for guideline development Ver. 1.0. Tokyo: Japan Council for Quality Health Care. Accessed 31 Mar 2014 (Japanese).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献